• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡啶及其衍生物对血栓素合成和血小板聚集的抑制作用。

Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.

作者信息

Tai H H, Lee N, Tai C L

出版信息

Adv Prostaglandin Thromboxane Res. 1980;6:447-52.

PMID:7189951
Abstract

Pyridine inhibited the conversion of PG endoperoxide to TXA2 catalyzed by TX synthetase from human platelet and swine lung microsomes. The inhibitory potency of pyridine is abolished by derivatizing pyridine at the 2-position but is increased by introducing hydrophobic substituents at 3- or 4-positions, with 3-substituted pyridines being the most potent inhibitors. Inhibition by pyridine and its derivatives was also selective, since other enzymes in the arachidonic acid cascade were not significantly affected. Pyridine and the active derivatives also inhibited human platelet aggregation induced by arachidonic acid or ADP.

摘要

吡啶抑制了由人血小板和猪肺微粒体中的血栓素合成酶催化的前列腺素内过氧化物向血栓素A2的转化。吡啶在2-位衍生化后其抑制效力消失,但在3-或4-位引入疏水取代基后抑制效力增强,其中3-取代吡啶是最有效的抑制剂。吡啶及其衍生物的抑制作用也是具有选择性的,因为花生四烯酸级联反应中的其他酶未受到显著影响。吡啶及其活性衍生物还抑制了由花生四烯酸或二磷酸腺苷诱导的人血小板聚集。

相似文献

1
Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.吡啶及其衍生物对血栓素合成和血小板聚集的抑制作用。
Adv Prostaglandin Thromboxane Res. 1980;6:447-52.
2
Selective inhibition of thromboxane synthetase by pyridine and its derivatives.
Arch Biochem Biophys. 1980 Sep;203(2):758-63. doi: 10.1016/0003-9861(80)90236-2.
3
Biology and biochemistry of thromboxane synthetase inhibitors.
Adv Prostaglandin Thromboxane Leukot Res. 1983;11:235-40.
4
Selective inhibitor of thromboxane synthetase: pyridine and its derivatives.
Adv Prostaglandin Thromboxane Res. 1980;6:443-5.
5
Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.1-烷基咪唑衍生物(血栓素A合成酶抑制剂)对血小板聚集的抑制作用
Prostaglandins. 1981 Apr;21(4):543-54. doi: 10.1016/0090-6980(81)90003-4.
6
Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.9,11-氮杂前列腺-5,13-二烯酸对人血小板血栓素合成酶的抑制作用。
Proc Natl Acad Sci U S A. 1977 Sep;74(9):4007-11. doi: 10.1073/pnas.74.9.4007.
7
Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.血栓素合酶抑制剂对血栓素受体脱敏血小板聚集的抑制作用比对正常血小板更有效:腺苷酸环化酶上调的作用
J Pharmacol Exp Ther. 1995 Dec;275(3):1497-505.
8
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.腺苷酸环化酶激活决定了血栓素合酶抑制剂对体外血小板聚集的影响。应答者与无应答者血小板的比较。
J Pharmacol Exp Ther. 1988 Jul;246(1):301-7.
9
Highly selective inhibitors of thromboxane synthetase. 2. Pyridine derivatives.血栓素合成酶的高选择性抑制剂。2. 吡啶衍生物。
J Med Chem. 1981 Oct;24(10):1149-55. doi: 10.1021/jm00142a006.
10
9,11-Iminoepoxyprosta-5,13-dienoic acid is a selective thromboxane A2 synthetase inhibitor.
Biochim Biophys Acta. 1979 May 25;573(2):238-44. doi: 10.1016/0005-2760(79)90057-2.

引用本文的文献

1
Bendectin and fetal malformations.多潘立酮与胎儿畸形
Can Med Assoc J. 1981 Feb 1;124(3):259.
2
Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.一种吡啶衍生物血栓素合成酶抑制剂及其无活性异构体对大鼠内毒素休克的影响。
Br J Pharmacol. 1983 Apr;78(4):725-32. doi: 10.1111/j.1476-5381.1983.tb09426.x.
3
Mechanism of inhibition of cyclo-oxygenase in human blood platelets by carbamate insecticides.氨基甲酸酯类杀虫剂对人血小板中环氧化酶的抑制机制。
Biochem J. 1988 Feb 15;250(1):103-10. doi: 10.1042/bj2500103.
4
The potential role of thromboxane inhibitors in preventing myocardial ischaemic injury.血栓素抑制剂在预防心肌缺血性损伤中的潜在作用。
Drugs. 1990 Nov;40(5):657-65. doi: 10.2165/00003495-199040050-00002.